Kathleen Villamejor

Kathleen Villamejor has extensive work experience in the field of clinical operations. Kathleen is currently working as the Executive Director of Clinical Operations at Pardes Biosciences since January 2022. Prior to this, they held the role of Senior Director of Clinical Operations at Nektar Therapeutics from April 2021 to January 2022.

From 2015 to 2021, Kathleen worked at Orbus Therapeutics, Inc. In this company, they held various positions including Senior Director of Clinical Operations from February 2019 to April 2021, and Director of Clinical Operations from November 2015 to February 2019.

Before joining Orbus Therapeutics, Inc., Kathleen worked at Gilead Sciences where they served as a Senior Clinical Program Manager from January 2015 to November 2015. Prior to that, they held the positions of Clinical Program Manager from February 2012 to January 2015, Associate Manager of Clinical Operations from 2011 to 2012, and Principal Clinical Research Associate from December 2009 to February 2011.

Earlier in their career, Kathleen held various roles at Proteolix as a Senior Clinical Research Associate from September 2008 to October 2009, at Affymax, Inc. as a Senior Clinical Research Associate from March 2007 to September 2008, at Nuvelo, Inc. as a Clinical Research Associate from April 2006 to March 2007, at Scios, Inc. as a Clinical Research Associate from April 2004 to April 2006, at MedImmune Vaccines, Inc. as a Clinical Research Associate from January 2003 to April 2004, and at Millennium Pharmaceuticals, Inc. as a Validation Specialist from August 2001 to January 2003.

Kathleen Villamejor obtained their Bachelor of Science (BS) degree in Health Science from California State University - East Bay. Kathleen pursued their education at the university from 1993 to 1999.